Non-genomic signaling of steroid receptors in cancer - Archive ouverte HAL Access content directly
Journal Articles Molecular and Cellular Endocrinology Year : 2021

Non-genomic signaling of steroid receptors in cancer


Steroid receptors (SRs) are members of the nuclear receptor family, which are ligand-activated transcription factors. SRs regulate many physiological functions including development and reproduction, though they can also be involved in several pathologies, especially cancer. Highly controlled cellular responses to steroids involve transcriptional regulation (genomic activity) combined with direct activation of signaling cascades (non-genomic activity). Non-genomic signaling has been extensively studied in cancer, mainly in breast cancer for ER and PR, and prostate cancer for AR. Even though most of the studies have been conducted in cells, some of them have been confirmed in vivo, highlighting the relevance of this pathway in cancer. This review provides an overview of the current and emerging knowledge on non-genomic signaling with a focus on breast and prostate cancers and its clinical relevance. A thorough understanding of ER, PR, AR and GR non-genomic pathways may open new perspectives for the development of therapeutic strategies.

Dates and versions

hal-03870131 , version 1 (24-11-2022)



Charlène Thiebaut, Virginie Vlaeminck-Guillem, Olivier Trédan, Coralie Poulard, Muriel Le Romancer. Non-genomic signaling of steroid receptors in cancer. Molecular and Cellular Endocrinology, 2021, 538, pp.111453. ⟨10.1016/j.mce.2021.111453⟩. ⟨hal-03870131⟩
5 View
0 Download



Gmail Facebook Twitter LinkedIn More